Purpose: The transjugular liver biopsy is performed in patients with coagulopathy to evaluate diffuse hepatopathies. Using a jugular venous access, a liver vein is cannulated and a transvascular biopsy taken. The two techniques in use are the aspiration biopsy with a modified 15G or 16G Ross needle used for TIPS and the core biopsy with a Trucut needle. The sampling is quite similar for these techniques, but the costs are significantly different. This study is a meta-analysis of data published on both techniques to search for clinical evidence that justifies the use of the more expensive Trucut needle or that finds aspiration with the less expensive Ross needle equivalent.
Materials and methods: The study includes 16 publications that were published between 1996 and 2002 and provided reliable information on technical success rate, complications and adequate histology. The data on 1374 procedures were analyzed, comprising 436 aspiration biopsies and 938 Trucut biopsies.
Results: Considering both procedures together, 95.9 % of the procedures were technically successful and 92.2% of the histologic samples diagnostically adequate. The technical success rate was 96.7 % for the Trucut-biopsies and 94.4 % for the aspiration biopsies. The corresponding rates of obtaining diagnostically adequate histologic samples were 92.5 % and 91.5 %, respectively. The complication rate of the entire population studied was 0.65 % without significant difference found between the two methods. With a list price of 420 Euro, the Trucut system costs about 200 Euro more than the Ross needle, which is listed as approximately 220 Euro.
Conclusion: In the absence of any significant differences between both techniques for transjugular liver biopsies, economic considerations make the aspiration biopsy with the modified Ross needle preferable over the Trucut needle biopsy.